Affiliation:
1. Division of Hematology/Medical Oncology and
2. Division of Critical Care, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada; and
3. Department of Medical Oncology & Hematology, Cancercare Manitoba, Winnipeg, MB, Canada
Abstract
Abstract
Thrombocytopenia is common among patients admitted to the intensive care unit (ICU). Multiple pathophysiological mechanisms may contribute, including thrombin-mediated platelet activation, dilution, hemophagocytosis, extracellular histones, ADAMTS13 deficiency, and complement activation. From the clinical perspective, the development of thrombocytopenia in the ICU usually indicates serious organ system derangement and physiologic decompensation rather than a primary hematologic disorder. Thrombocytopenia is associated with bleeding, transfusion, and adverse clinical outcomes including death, though few deaths are directly attributable to bleeding. The assessment of thrombocytopenia begins by looking back to the patient’s medical history and presenting illness. This past information, combined with careful observation of the platelet trajectory in the context of the patient’s clinical course, offers clues to the diagnosis and prognosis. Management is primarily directed at the underlying disorder and transfusion of platelets to prevent or treat clinical bleeding. Optimal platelet transfusion strategies are not defined, and a conservative approach is recommended.
Publisher
American Society of Hematology
Reference44 articles.
1. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review;Hui;Chest,2011
2. Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes;Williamson;Can J Anaesth,2013
3. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes;Williamson;Chest,2013
4. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis;Lauzier;Intensive Care Med,2013
5. Dalteparin versus unfractionated heparin in critically ill patients;Cook;N Engl J Med,2011
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献